journal article·2025-01-06Open access

Advancements in skeletal muscle tissue engineering: strategies for repair and regeneration of skeletal muscle beyond self-repair

Lei Qi, Fengyuan Zhang, Kexin Wang, Bingqian Chen, Xia Li, Jin Xu, Jiacheng Sun, Boya Liu, Zihui Gao, Yanan Ji, Leilei Gong, Youhua Wang, Xinlei Yao, Xiaosong Gu, Hualin Sun

Abstract

Abstract Skeletal muscle is a vital organ of exercise and energy metabolism, playing a crucial role in maintaining body posture, enabling movement and supporting overall health. When skeletal muscle undergoes minor injuries, it has the inherent ability to self-repair and regain function. However, the ability of skeletal muscle self-repair is affected in severe muscle damage, resulting in significant muscle loss and functional impairments. For the severe muscle injury, tissue engineering strategies are used as the new methods to promote the repair and regeneration of skeletal muscle. Skeletal muscle tissue engineering (SMTE) aims to repair or regenerate skeletal muscle using seed cells, scaffolds, bioactive molecules or their combinations to reverse muscle loss caused by traumatic injury or congenital muscle defects. In this study, we provide an overview of the structure and contraction process of skeletal muscle, as well as its mechanisms of natural repair and regeneration. We describe the seed cells with myogenic potential and show natural, synthetic and composite biomaterials, as well as advanced technologies for manufacturing scaffolds used in SMTE. SMTE has broad prospects, but it still faces many challenges before clinical application. The continued advancement of muscle tissue engineering will yield innovative outcomes with significant clinical potential for skeletal muscle regeneration.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications · Muscle Physiology and Disorders

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Affiliated Hospital of Nantong University, Medical School of Nantong University, Co-Innovation Center of Neuroregeneration, Nantong University , Nantong, Jiangsu Province 226001, People’s Republic of

Department of Emergency Medicine, Affiliated Hospital of Nantong University , Nantong, Jiangsu Province 226001, People’s Republic of

Department of Orthopedics, Changshu Hospital Affiliated to Soochow University, First People’s Hospital of Changshu City , Changshu, Jiangsu Province 215500, People’s Republic of

Departmentof Basic Medicine, Kangda College of Nanjing Medical University , Lianyungang, Jiangsu Province 222000, People’s Republic of

Research and Development Center for E-Learning, Ministry of Education , Beijing 100816, People’s Republic of

Funding

National Natural Science Foundation of China · Natural Science Foundation of Jiangsu Province

References (100+)

Show source-provided references
1. Inflammation: roles in skeletal muscle atrophy
2. PQQ ameliorates skeletal muscle atrophy, mitophagy and fiber type transition induced by denervation via inhibition of the inflammatory signaling pathways10.21037/atm.2019.08.101 ↗
3. Salidroside attenuates denervation-induced skeletal muscle atrophy through negative regulation of pro-inflammatory cytokine10.3389/fphys.2019.00665 ↗
4. SKP-SC-EVs mitigate denervated muscle atrophy by inhibiting oxidative stress and inflammation and improving microcirculation
5. Isoquercitrin delays denervated soleus muscle atrophy by inhibiting oxidative stress and inflammation10.3389/fphys.2020.00988 ↗
6. Mechanistic role of reactive oxygen species and therapeutic potential of antioxidants in denervation- or fasting-induced skeletal muscle atrophy10.3389/fphys.2018.00215 ↗
7. Celecoxib alleviates denervation-induced muscle atrophy by suppressing inflammation and oxidative stress and improving microcirculation10.1016/j.bcp.2022.115186 ↗
8. MuSCs and IPCs: roles in skeletal muscle homeostasis, aging and injury10.1007/s00018-023-05096-w ↗
9. Single-cell RNA-seq reveals novel interaction between muscle satellite cells and fibro-adipogenic progenitors mediated with FGF7 signalling10.1002/jcsm.13484 ↗
10. Adult stem cell sources for skeletal and smooth muscle tissue engineering10.1186/s13287-022-02835-x ↗
11. Regenerative medicine for skeletal muscle loss: a review of current tissue engineering approaches10.1007/s10856-020-06476-5 ↗
12. Stem cell-based strategies for skeletal muscle tissue engineering10.1002/term.3355 ↗
13. Long-term longitudinal study on swine VML model10.1186/s13062-023-00399-1 ↗
14. Tissue engineering applied to skeletal muscle: strategies and perspectives10.3390/bioengineering9120744 ↗
15. A mouse model of volumetric muscle loss and therapeutic scaffold implantation10.1038/s41596-024-01059-y ↗
16. Potential therapeutic strategies for skeletal muscle atrophy
17. Nutritional strategies for muscle atrophy: current evidence and underlying mechanisms10.1002/mnfr.202300347 ↗
18. Decellularized extracellular matrix-based composite scaffolds for tissue engineering and regenerative medicine10.1093/rb/rbad107 ↗
19. Biomaterials-Based technologies in skeletal muscle tissue engineering10.1002/adhm.202304196 ↗
20. Recent advances in regenerative biomaterials10.1093/rb/rbac098 ↗
21. Preparation, properties, and application of graphene-based materials in tissue engineering scaffolds10.1089/ten.teb.2021.0127 ↗
22. Biodegradable materials and the tissue engineering of nerves10.1016/j.eng.2021.10.011 ↗
23. Nano-biomaterials and advanced fabrication techniques for engineering skeletal muscle tissue constructs in regenerative medicine10.1186/s40580-023-00398-y ↗
24. Biomaterials for recruiting and activating endogenous stem cells in situ tissue regeneration10.1016/j.actbio.2022.03.014 ↗
25. Antioxidant and anti-inflammatory injectable hydrogel microspheres for in situ treatment of tendinopathy10.1093/rb/rbae007 ↗
26. 3D human induced pluripotent stem cell-derived bioengineered skeletal muscles for tissue, disease and therapy modeling10.1038/s41596-022-00790-8 ↗
27. Skeletal muscle tissue engineering: biomaterials-based strategies for the treatment of volumetric muscle loss10.3390/bioengineering7030085 ↗
28. Highly contractile 3D tissue engineered skeletal muscles from human iPSCs reveal similarities with primary myoblast-derived tissues10.1016/j.stemcr.2023.08.014 ↗
29. Macrophage involvement in aging-associated skeletal muscle regeneration10.3390/cells12091214 ↗
30. Isolating myofibrils from skeletal muscle biopsies and determining contractile function with a nano-Newton resolution force transducer10.3791/61002 ↗
31. Biochemical and structural basis of the passive mechanical properties of whole skeletal muscle10.1113/JP280867 ↗
32. Structure-function relationships in the skeletal muscle extracellular matrix10.1016/j.jbiomech.2023.111593 ↗
33. Skeletal muscle in health and disease10.1242/dmm.042192 ↗
34. The myonuclear domain in adult skeletal muscle fibres: past, present and future10.1113/JP283658 ↗
35. Extracellular matrix: brick and mortar in the skeletal muscle stem cell niche10.3389/fcell.2022.1056523 ↗
36. Skeletal muscle: a review of molecular structure and function, in health and disease10.1002/wsbm.1462 ↗
37. 3D bioprinting in skeletal muscle tissue engineering10.1002/smll.201805530 ↗
38. Adenosine monophosphate activated protein kinase contributes to skeletal muscle health through the control of mitochondrial function10.3389/fphar.2022.947387 ↗
39. Transplantation of allogeneic PW1(pos)/Pax7(neg) interstitial cells enhance endogenous repair of injured porcine skeletal muscle10.1016/j.jacbts.2017.08.002 ↗
40. Development of a cell-free strategy to recover aged skeletal muscle after disuse10.1113/JP282867 ↗
41. Human skeletal muscle-derived CD133(+) cells form functional satellite cells after intramuscular transplantation in immunodeficient host mice10.1038/mt.2014.26 ↗
42. Identification of underexplored mesenchymal and vascular-related cell populations in human skeletal muscle10.1152/ajpcell.00364.2022 ↗
43. Metabolic reprogramming of fibro/adipogenic progenitors facilitates muscle regeneration10.26508/lsa.202000660 ↗
44. Cellular interplay in skeletal muscle regeneration and wasting: insights from animal models10.1002/jcsm.13103 ↗
45. Oxidation alters myosin-actin interaction and force generation in skeletal muscle filaments10.1152/ajpcell.00427.2021 ↗
46. CAP2 deficiency delays myofibril actin cytoskeleton differentiation and disturbs skeletal muscle architecture and function10.1073/pnas.1813351116 ↗
47. Dependence of thick filament structure in relaxed mammalian skeletal muscle on temperature and interfilament spacing10.1085/jgp.202012713 ↗
48. Dependence of myosin filament structure on intracellular calcium concentration in skeletal muscle10.1085/jgp.202313393 ↗
49. Skeletal muscle structure, physiology, and function10.1016/B978-0-323-98818-6.00013-3 ↗
50. Skeletal muscle: a brief review of structure and function10.1007/s00223-014-9915-y ↗
51. Thick filament activation is different in fast- and slow-twitch skeletal muscle10.1113/JP283574 ↗
52. Targeting the DP2 receptor alleviates muscle atrophy and diet-induced obesity in mice through oxidative myofiber transition10.1002/jcsm.13136 ↗
53. Puerarin ameliorates skeletal muscle wasting and fiber type transformation in STZ-induced type 1 diabetic rats10.1016/j.biopha.2020.110977 ↗
54. Celecoxib attenuates hindlimb unloading-induced muscle atrophy via suppressing inflammation, oxidative stress and ER stress by inhibiting STAT310.1007/s10787-024-01454-7 ↗
55. Skeletal muscle fiber type in hypoxia: adaptation to High-Altitude exposure and under conditions of pathological hypoxia10.3389/fphys.2018.01450 ↗
56. Effects of protocatechuic acid on antioxidant capacity, mitochondrial biogenesis and skeletal muscle fiber transformation10.1016/j.jnutbio.2023.109327 ↗
57. Grape seed proanthocyanidin extract promotes skeletal muscle fiber type transformation via AMPK signaling pathway10.1016/j.jnutbio.2020.108462 ↗
58. Vascularized and innervated skeletal muscle tissue engineering10.1002/adhm.201900626 ↗
59. An overview of the role of neutrophils in innate immunity, inflammation and host-biomaterial integration10.1093/rb/rbw041 ↗
60. CGRP sensory neurons promote tissue healing via neutrophils and macrophages10.1038/s41586-024-07237-y ↗
61. Inflammation and skeletal muscle regeneration: leave it to the macrophages!10.1016/j.it.2020.04.006 ↗
62. Featured characteristics and pivotal roles of satellite cells in skeletal muscle regeneration10.1007/s10974-019-09553-7 ↗
63. Regulatory T cells in skeletal muscle repair and regeneration: recent insights10.1038/s41419-022-05142-8 ↗
64. p38/MKP-1-regulated AKT coordinates macrophage transitions and resolution of inflammation during tissue repair10.1083/jcb.201104053 ↗
65. Skeletal muscle regeneration failure in ischemic-damaged limbs is associated with pro-inflammatory macrophages and premature differentiation of satellite cells10.1186/s13073-023-01250-y ↗
66. Inflammation during post-injury skeletal muscle regeneration10.1016/j.semcdb.2021.05.031 ↗
67. Role of macrophages during skeletal muscle regeneration and hypertrophy-implications for immunomodulatory strategies10.14814/phy2.15480 ↗
68. Satellite cells, the engines of muscle repair10.1038/nrm3265 ↗
69. Mechanisms of skeletal muscle repair and regeneration in health and disease10.1111/febs.16577 ↗
70. Transcription regulation of Tceal7 by the triple complex of Mef2c, Creb1 and Myod
71. The role of mitophagy in skeletal muscle damage and regeneration10.3390/cells12050716 ↗
72. The regenerating skeletal muscle niche drives satellite cell return to quiescence10.1016/j.isci.2022.104444 ↗
73. Conductive biomaterials for muscle tissue engineering10.1016/j.biomaterials.2019.119584 ↗
74. Porous biomaterial scaffolds for skeletal muscle tissue engineering10.3389/fbioe.2023.1245897 ↗
75. Craniomaxillofacial derived bone marrow mesenchymal stem/stromal cells (BMSCs) for craniomaxillofacial bone tissue engineering: a literature review10.1016/j.jormas.2022.06.002 ↗
76. Personalized gene and cell therapy for Duchenne muscular dystrophy10.1016/j.nmd.2018.06.009 ↗
77. Role of hydrogels in bone tissue engineering: how properties shape regeneration10.1166/jbn.2020.2997 ↗
78. Protocols for the preparation and characterization of decellularized tissue and organ scaffolds for tissue engineering10.2144/btn-2020-0141 ↗
79. Skeletal Muscle-Derived human mesenchymal stem cells: influence of different culture conditions on proliferative and myogenic capabilities10.3389/fphys.2020.553198 ↗
80. Skeletal muscle regeneration via the chemical induction and expansion of myogenic stem cells in situ or in vitro10.1038/s41551-021-00696-y ↗
81. Pre-clinical cell therapeutic approaches for repair of volumetric muscle loss10.3390/bioengineering7030097 ↗
82. Co-delivery of fibrin-laminin hydrogel with mesenchymal stem cell spheroids supports skeletal muscle regeneration following trauma10.1002/term.3243 ↗
83. Harnessing knee joint resident mesenchymal stem cells in cartilage tissue engineering10.1016/j.actbio.2023.07.024 ↗
84. The application of bone marrow mesenchymal stem cells and biomaterials in skeletal muscle regeneration10.1016/j.reth.2020.11.002 ↗
85. Combined use of bone marrow-derived mesenchymal stromal cells (BM-MSCs) and platelet rich plasma (PRP) stimulates proliferation and differentiation of myoblasts in vitro: new therapeutic perspectives for skeletal muscle repair/regeneration10.1007/s00441-018-2792-3 ↗
86. Tetramethylpyrazine induces the release of BDNF from BM-MSCs through activation of the PI3K/AKT/CREB pathway10.1002/cbin.11687 ↗
87. Mesenchymal stem cell therapies in the treatment of musculoskeletal diseases10.1016/j.pmrj.2013.05.007 ↗
88. Long-term effectiveness of local BM-MSCs for skeletal muscle regeneration: a proof of concept obtained on a pig model of severe radiation burn10.1186/s13287-018-1051-6 ↗
89. Long-term contribution of human bone marrow mesenchymal stromal cells to skeletal muscle regeneration in mice10.3727/096368910X522117 ↗
90. Hypoxia preconditioned bone marrow-derived mesenchymal stromal/stem cells enhance myoblast fusion and skeletal muscle regeneration10.1186/s13287-021-02530-3 ↗
91. ADSC-based cell therapies for musculoskeletal disorders: a review of recent clinical trials10.3390/ijms221910586 ↗
92. The therapeutic role of ADSC-EVs in skin regeneration10.3389/fmed.2022.858824 ↗
93. Advanced techniques for skeletal muscle tissue engineering and regeneration10.3390/bioengineering7030099 ↗
94. Adipose Tissue-Derived stem cells in regenerative medicine10.1159/000448180 ↗
95. Human ADSC xenograft through IL-6 secretion activates M2 macrophages responsible for the repair of damaged muscle tissue10.1186/s13287-019-1188-y ↗
96. MYOD mediates skeletal myogenic differentiation of human amniotic fluid stem cells and regeneration of muscle injury10.1186/scrt358 ↗
97. Amniotic fluid stem cells restore the muscle cell niche in a HSA-Cre, smn(F7/F7) mouse model10.1002/stem.1134 ↗
98. Therapeutic potential of amniotic fluid stem cells10.2174/1574888X11308020002 ↗
99. Human neuromuscular junction on a chip: impact of amniotic fluid stem cell extracellular vesicles on muscle atrophy and NMJ integrity10.3390/ijms24054944 ↗
100. Transplantation of human iPSC-derived muscle stem cells in the diaphragm of Duchenne muscular dystrophy model mice10.1371/journal.pone.0266391 ↗